| Previous Close | 0.1350 |
| Open | 0.1300 |
| Bid | 0.1300 x 0 |
| Ask | 0.1350 x 0 |
| Day's Range | 0.1300 - 0.1400 |
| 52 Week Range | 0.0450 - 0.2400 |
| Volume | 142,146 |
| Avg. Volume | 819,409 |
| Market Cap | 30.417M |
| Beta (5Y Monthly) | 1.15 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0210 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Newsfile
MYM Continues to Secure Additional Support for Merger with IMCC
Total voting support agreements for the Transaction now represent 44.4%, or 162.7 million, of the total votes outstanding including all senior management and board membersShareholders to benefit from a global platform of premium and super premium brands and distribution through Canada, Israel and EuropeThe Transaction has been approved by an MYM Special Committee of Independent Directors Vancouver, British Columbia--(Newsfile Corp. - April 19, 2021) - MYM Nutraceuticals Inc. (CSE: MYM) (OTCQB: MYMMF) ("MYM" or ...
- Newsfile
IM Cannabis to Acquire MYM Nutraceuticals and Its Licensed Producer Subsidiary, Highland Grow
Highland Grow is currently profitable on an EBITDA basis and the Transaction is expected to be immediately accretive to IMCHighland Grow is expected to generate net revenue of $29 million and $38 million and gross margins of 34% to 36% in 2021 and 2022, respectively[1]Purchase price implies 2.3x net revenue and 6.7x EBITDA in 2022 with synergiesMYM shareholders will receive 0.022 IMC shares for each MYM share, representing a price of $0.195 based on ...
